Mice lacking flt 3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells , dendritic cells , and natural killer cells

The ligand for the receptor tyrosine kinase fms-like tyrosine kinase 3 (flt3), also referred to as fetal liver kinase-2 (flk-2), has an important role in hematopoiesis. The flt3 ligand (flt3L) is a growth factor for hematopoietic progenitors and induces hematopoietic progenitor and stem cell mobilization in vivo. In addition, when mice are treated with flt3L immature B cells, natural killer (NK) cells and dendritic cells (DC) are expanded in vivo. To further elucidate the role of flt3L in hematopoiesis, mice lacking flt3L (flt3L 2/2) were generated by targeted gene disruption. Leukocyte cellularity was reduced in the bone marrow, peripheral blood, lymph nodes (LN), and spleen. Thymic cellularity, blood hematocrit, and platelet numbers were not affected. Significantly reduced numbers of myeloid and B-lymphoid progenitors were noted in the BM of flt3L 2/2 mice. In addition a marked deficiency of NK cells in the spleen was noted. DC numbers were also reduced in the spleen, LN, and thymus. Both myeloid-related (CD11c 11 CD8a2) and lymphoid-related (CD11c 11 CD8a1) DC numbers were affected. We conclude that flt3L has an important role in the expansion of early hematopoietic progenitors and in the generation of mature peripheral leukocytes. (Blood. 2000;95: 3489-3497)

[1]  R. Maldonado-López,et al.  CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo , 1999, The Journal of experimental medicine.

[2]  A. Maung,et al.  Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. , 1998, Journal of immunology.

[3]  P. Gaffney,et al.  FLT-3 Ligand and Marrow Stroma-Derived Factors Promote CD3γ, CD3δ, CD3ζ, and RAG-2 Gene Expression in Primary Human CD34+LIN−DR− Marrow Progenitors , 1998 .

[4]  S. Lyman,et al.  c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. , 1998, Blood.

[5]  M. Lotze,et al.  FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma. , 1998, Cancer research.

[6]  S. Camus,et al.  The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells. , 1998, Experimental hematology.

[7]  D. Williams,et al.  Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. , 1997, Blood.

[8]  B. Pulendran,et al.  Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. , 1997, Journal of immunology.

[9]  E A Wiebke,et al.  Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. , 1997, Cancer research.

[10]  O. Majdic,et al.  flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. , 1997, Blood.

[11]  M. Lotze,et al.  FLT3 ligand induces the generation of functionally active dendritic cells in mice. , 1997, Cellular immunology.

[12]  Robert E. Miller,et al.  Flt3 ligand induces tumor regression and antitumor immune responses in vivo , 1997, Nature Medicine.

[13]  T. Moore,et al.  Differential effects of Flk-2/Flt-3 ligand and stem cell factor on murine thymic progenitor cells. , 1997, Journal of immunology.

[14]  A. Dunn,et al.  The influence of granulocyte/macrophage colony‐stimulating factor on dendritic cell levels in mouse lymphoid organs , 1997, European journal of immunology.

[15]  S. Jacobsen,et al.  Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3. , 1996, Blood.

[16]  A. Gratwohl,et al.  Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. , 1996, Blood.

[17]  Li Wu,et al.  Dendritic Cell Development in Culture from Thymic Precursor Cells in the Absence of Granulocyte/Macrophage Colony-stimulating Factor , 1996, The Journal of experimental medicine.

[18]  J. Letterio,et al.  A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology:  The Skin of   Transforming Growth Factor β1 Null Mice Is Devoid of  Epidermal Langerhans Cells , 1996, The Journal of experimental medicine.

[19]  A. Kelso,et al.  A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. , 1996, Journal of immunology.

[20]  E. Maraskovsky,et al.  Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified , 1996, The Journal of experimental medicine.

[21]  D. Williams,et al.  Hematologic effects of flt3 ligand in vivo in mice. , 1996, Blood.

[22]  S. Jacobsen,et al.  Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. , 1996, Blood.

[23]  R. Rottapel,et al.  Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin‐11 and interleukin‐7 , 1996, European journal of immunology.

[24]  D. Rennick,et al.  flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. , 1996, Journal of immunology.

[25]  S. Kalams,et al.  Generation of human T lymphocytes from bone marrow CD34+ cells in vitro , 1996, Nature Medicine.

[26]  J. Prchal,et al.  Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. , 1995, Blood.

[27]  David A. Williams,et al.  Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells. , 1995, Blood.

[28]  H. Broxmeyer,et al.  Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells. , 1995, Experimental hematology.

[29]  R. Derynck,et al.  Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor , 1995, Nature.

[30]  R. Hardy,et al.  Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. , 1995, Journal of immunology.

[31]  K. Herrup,et al.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.

[32]  E. Wagner,et al.  Strain-dependent epithelial defects in mice lacking the EGF receptor. , 1995, Science.

[33]  S. Goff,et al.  Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. , 1995, Immunity.

[34]  C. Hannum,et al.  FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. , 1995, Blood.

[35]  F. Hirayama,et al.  The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. , 1995, Blood.

[36]  R. Kastelein,et al.  FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. , 1995, Blood.

[37]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[38]  T. Mcclanahan,et al.  Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs , 1994, Nature.

[39]  M. Ratajczak,et al.  STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Farrah,et al.  Molecular cloning of a ligand for the flt3 flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells , 1993, Cell.

[41]  D. Metcalf.  Hematopoietic regulators: redundancy or subtlety? , 1993, Blood.

[42]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[43]  J. Tikerpae,et al.  Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. , 1992, Journal of immunology.

[44]  S. Carsons,et al.  TNF in combination with GM‐CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages , 1992, Journal of leukocyte biology.

[45]  J. Banchereau,et al.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. , 1992, Nature.

[46]  D. Pardoll,et al.  A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations , 1991, Cell.

[47]  E. Russell.  Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.